RFP CLOSED: Prime Gene Editing Strategies or Cell Therapy

The MSF is proud to support projects to help discover potential therapies for Myhre Syndrome. Learn more about our recent funding recipients below.

Please contact apindon@myhresyndrome.org to discuss this and future opportunities.

Grant Overhead Policy
Myhre Syndrome Foundation will not support indirect costs, overhead costs, or other similar institutional levies in excess of 5% of the total award amount. Fringe benefits for personnel salaries are allowable.